About Arcis Biotechnology
Arcis Biotechnology is a company based in Daresbury (United Kingdom) founded in 2009. Arcis Biotechnology has raised $9.59 million across 8 funding rounds from investors including Gov.uk, Calculus Capital and European Union. The company has 12 employees as of December 31, 2021. Arcis Biotechnology operates in a competitive market with competitors including Parse Biosciences, Biofidelity, RareCyte, Qiagen and RainDance, among others.
- Headquarter Daresbury, United Kingdom
- Employees 12 as on 31 Dec, 2021
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Arcis Biotechnology Limited
- Date of Incorporation 18 Apr, 2013
- Jurisdiction LONDON
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$9.59 M (USD)
in 8 rounds
-
Latest Funding Round
$66.25 K (USD), Grant
Jan 01, 2020
-
Investors
Gov.uk
& 2 more
-
Employee Count
12
as on Dec 31, 2021
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Arcis Biotechnology
Arcis Biotechnology has successfully raised a total of $9.59M across 8 strategic funding rounds. The most recent funding activity was a Grant round of $66.25 thousand completed in January 2020. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Arcis Biotechnology
Arcis Biotechnology has secured backing from 3 investors, including institutional and venture fund investors. Prominent investors backing the company include Gov.uk, Calculus Capital and European Union.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
UK venture capital investments are managed by Calculus Capital.
|
Locked | Locked | Locked | |
|
Government entites focused on freedom, democracy, equality and the rule of law, promoting peace and stability
|
Locked | Locked | Locked | |
|
Online government services and information are provided to users.
|
Locked | Locked | Locked |
Investor details for Arcis Biotechnology
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Arcis Biotechnology
Investment portfolio details for Arcis Biotechnology
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Arcis Biotechnology
Detailed financials for Arcis Biotechnology
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Arcis Biotechnology Comparisons
Peer comparison for Arcis Biotechnology
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Arcis Biotechnology
Arcis Biotechnology operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Parse Biosciences, Biofidelity, RareCyte, Qiagen and RainDance, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
RNA-sequencing transcriptome kits for health data analysis are developed.
|
|
| Locked | Locked | Locked |
Molecular diagnostic assays are developed for target DNA sequence detection.
|
|
| Locked | Locked | Locked |
Developer of technologies for the analysis of rare and single cells in the blood
|
|
| Locked | Locked | Locked |
Products and reagents for molecular diagnostic assays are supplied.
|
|
| Locked | Locked | Locked |
Developer of nucleic acid detection and quantification systems
|
|
| Locked | Locked | Locked |
Electrophoresis-based in vitro diagnostics products are developed and provided.
|
Detailed competitors of Arcis Biotechnology
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Arcis Biotechnology
Complete news archive for Arcis Biotechnology
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Arcis Biotechnology
Arcis Biotechnology was founded in 2009 and raised its 1st funding round 3 years after it was founded.
Arcis Biotechnology is headquartered in Daresbury, United Kingdom. It is registered at Daresbury, Cheshire, United Kingdom.
Arcis Biotechnology is a funded company, having raised a total of $9.59M across 8 funding rounds to date.
As of Dec 31, 2021, the latest employee count at Arcis Biotechnology is 12.
Arcis Biotechnology is a research and development company offers reagent kits and technology for genome isolation and amplification. It develops a surface protection technology that is designed to kill a spectrum of micro-organisms, including bacteria, viruses, germinating spores, fungi, mold, algae, and moss. Its PCR direct technology gives the potential to identify DNA samples and test for a range of elements. It provides its technology for developing bespoke additive applications for various international companies, including hard surface cleaners for consumer and healthcare usage, wound care and infection control, laundry, sealants, agriculture and conservatory, and patio care. Products developed by the company are Viral Sample Preparation Kits, Sample Prep Kit 50rxn, Arcis Blood Kit, and ArcisPathogen Kit 50rnx.
Arcis Biotechnology's top competitors include Neogen, Qiagen and Parse Biosciences.
Arcis Biotechnology has 3 investors. Key investors include Gov.uk, Calculus Capital, and European Union.